Vericel Share Price Today
(NASDAQ: VCEL)

Name: Vericel Share Price Today (NASDAQ: VCEL) - Vericel Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vericel share price is $52 & ₹4,509.75 as on 22 Feb 2025, 2.30 'hrs' IST

$52

▲

-2.31

(-4.25%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Vericel share price in Dollar and Rupees. Guide to invest in Vericel stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vericel, along with analyst recommendations, forecasts, and comprehensive financials.

Vericel share price movements

Today's Low: $51.99
Today's High: $54.90
$52.00
0.02%
Downside
Day's Volatility :5.3%
Upside
5.28%
52 Weeks Low: $39.12
52 Weeks High: $63.00
$52.00
24.77%
Downside
52 Weeks Volatility :37.9%
Upside
17.46%

Vericel (VCEL) Returns

Period	Vericel Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.29%	1.6%	0.0%
6 Months	4.12%	-5.8%	0.0%
1 Year	8.15%	-1.0%	0.0%
3 Years	32.59%	15.7%	-9.0%

Vericel (VCEL) Key Statistics

in dollars & INR

Previous Close	$54.31
Open	$54.91
Today's High	$54.9
Today's Low	$51.99
Market Capitalization	$2.7B
Today's Volume	$410.8K
52 Week High	$63.0
52 Week Low	$39.12
Revenue TTM	$226.8M
EBITDA	$3.9M
Earnings Per Share (EPS)	$0.08
PE Ratio	678.88
Profit Margin	1.56%
Quarterly Earnings Growth YOY	1.05%
Return On Equity TTM	1.54%

How to invest in Vericel Stock (VCEL) from India?

It is very easy for Indian residents to invest directly in Vericel from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vericel stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vericel or VCEL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vericel or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vericel shares which would translate to 0.017 fractional shares of Vericel as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vericel, in just a few clicks!

Returns in Vericel (VCEL) for Indian investors in Rupees

The Vericel stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vericel investment value today

Current value as on today

₹1,12,802

Returns

₹12,802

(+12.8%)

Returns from Vericel Stock

₹8,153 (+8.15%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Vericel (VCEL)

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Vericel Stock from India on INDmoney has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vericel

BlackRock Inc
16.34%
Brown Capital Management, LLC
7.75%
Vanguard Group Inc
7.06%
State Street Corp
4.92%
FMR Inc
4.81%
Amvescap Plc.
4.80%

Analyst Recommendation on Vericel

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Vericel(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vericel Stock (VCEL)

What analysts predicted

Upside of 27.88%

Target:

$66.50

Current:

$52.00

Insights on Vericel Stock (Ticker Symbol: VCEL)

Price Movement
In the last 7 days, VCEL stock has moved down by -8.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 51.28M → 57.90M (in $), with an average increase of 5.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.68M → -901.0K (in $), with an average increase of 419.6% per quarter
VCEL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.0% return, outperforming this stock by 49.1%
VCEL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 69.9% return, outperforming this stock by 8.3%
Price to Sales
ForVCEL every $1 of sales, investors are willing to pay $11.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

VCEL Vericel Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$90.9M	↑ 42.13%
Net Income	$-8.1M	↓ 52.93%
Net Profit Margin	-8.96%	↑ 18.08%

	FY19	Y/Y Change
Revenue	$117.9M	↑ 29.71%
Net Income	$-7.9M	↓ 2.8%
Net Profit Margin	-6.71%	↑ 2.25%

	FY20	Y/Y Change
Revenue	$124.2M	↑ 5.37%
Net Income	$2.9M	↓ 136.21%
Net Profit Margin	2.31%	↑ 9.02%

	FY21	Y/Y Change
Revenue	$156.2M	↑ 25.77%
Net Income	$-7.5M	↓ 360.86%
Net Profit Margin	-4.78%	↓ 7.09%

	FY22	Y/Y Change
Revenue	$164.4M	↑ 5.24%
Net Income	$-16.7M	↑ 123.65%
Net Profit Margin	-10.17%	↓ 5.39%

	FY23	Y/Y Change
Revenue	$197.5M	↑ 20.17%
Net Income	$-3.2M	↓ 80.96%
Net Profit Margin	-1.61%	↑ 8.56%

	Q2 FY23	Q/Q Change
Revenue	$45.9M	↑ 11.96%
Net Income	$-5.0M	↓ 20.78%
Net Profit Margin	-10.93%	↑ 4.52%

	Q3 FY23	Q/Q Change
Revenue	$45.6M	↓ 0.74%
Net Income	$-3.7M	↓ 27.09%
Net Profit Margin	-8.03%	↑ 2.9%

	Q4 FY23	Q/Q Change
Revenue	$65.0M	↑ 42.59%
Net Income	$13.0M	↓ 455.0%
Net Profit Margin	19.99%	↑ 28.02%

	Q1 FY24	Q/Q Change
Revenue	$51.3M	↓ 21.1%
Net Income	$-3.9M	↓ 129.72%
Net Profit Margin	-7.53%	↓ 27.52%

	Q2 FY24	Q/Q Change
Revenue	$52.7M	↑ 2.69%
Net Income	$-4.7M	↑ 21.23%
Net Profit Margin	-8.89%	↓ 1.36%

	Q3 FY24	Q/Q Change
Revenue	$57.9M	↑ 9.96%
Net Income	$-901.0K	↓ 80.76%
Net Profit Margin	-1.56%	↑ 7.33%

	FY18	Y/Y Change
Profit	$58.7M	↑ 74.85%

	FY19	Y/Y Change
Profit	$80.3M	↑ 36.77%

	FY20	Y/Y Change
Profit	$84.2M	↑ 4.92%

	FY21	Y/Y Change
Profit	$106.0M	↑ 25.88%

	FY22	Y/Y Change
Profit	$109.8M	↑ 3.55%

	FY23	Y/Y Change
Profit	$135.6M	↑ 23.49%

	Q2 FY23	Q/Q Change
Profit	$29.9M	↑ 12.9%

	Q3 FY23	Q/Q Change
Profit	$30.6M	↑ 2.23%

	Q4 FY23	Q/Q Change
Profit	$48.5M	↑ 58.48%

	Q1 FY24	Q/Q Change
Profit	$35.4M	↓ 27.12%

	Q2 FY24	Q/Q Change
Profit	$36.6M	↑ 3.53%

	Q3 FY24	Q/Q Change
Profit	$41.7M	↑ 13.8%

	FY18	Y/Y Change
Operating Cash Flow	$-412.0K	↓ 96.87%
Investing Cash Flow	$-67.0M	↑ 4338.87%
Financing Cash Flow	$58.9M	↑ 216.86%

	FY19	Y/Y Change
Operating Cash Flow	$-7.2M	↑ 1643.45%
Investing Cash Flow	$10.6M	↓ 115.84%
Financing Cash Flow	$5.3M	↓ 91.06%

	FY20	Y/Y Change
Operating Cash Flow	$17.6M	↓ 344.63%
Investing Cash Flow	$-17.2M	↓ 261.66%
Financing Cash Flow	$6.4M	↑ 22.45%

	FY21	Y/Y Change
Operating Cash Flow	$29.0M	↑ 65.26%
Investing Cash Flow	$-3.5M	↓ 79.6%
Financing Cash Flow	$9.2M	↑ 42.38%

	FY22	Y/Y Change
Operating Cash Flow	$17.7M	↓ 39.09%
Investing Cash Flow	$-36.2M	↑ 934.16%
Financing Cash Flow	$1.0M	↓ 88.61%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$10.2M	↑ 29.72%
Investing Cash Flow	$-2.4M	↓ 186.0%
Financing Cash Flow	$1.2M	↑ 1016.82%

Vericel Technicals Summary

Sell

Neutral

Buy

Vericel is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Vericel (VCEL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vericel Corporation	-9.45%	4.12%	8.15%	32.59%	245.74%
Biontech Se	1.58%	37.14%	28.33%	-20.32%	255.59%
Regeneron Pharmaceuticals, Inc.	3.63%	-41.61%	-29.21%	13.2%	52.94%
Vertex Pharmaceuticals Incorporated	10.15%	0.33%	11.71%	110.26%	108.69%
Alnylam Pharmaceuticals, Inc.	-10.11%	-6.89%	57.94%	61.67%	112.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vericel Corporation	678.88	678.88	0.0	0.16	0.02	0.0	NA	5.23
Biontech Se	160.8	NA	0.04	-3.29	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	18.16	18.16	1.01	43.09	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.3	18.11	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.59	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vericel Corporation	Buy	$2.7B	245.74%	678.88	1.56%
Biontech Se	Buy	$28.3B	255.59%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$76.1B	52.94%	18.16	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$123.3B	108.69%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.5B	112.27%	NA	-12.37%

About Vericel

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Organization	Vericel
Employees	314
CEO	Mr. Dominick C. Colangelo Esq.
Industry	Health Technology

Management People of Vericel

Name	Title
Mr. Dominick C. Colangelo Esq.	CEO, President & Director
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer
Mr. Michael Halpin	Chief Operating Officer
Mr. Sean C. Flynn	Chief Legal Officer
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller
Mr. Eric Burns	Vice President of Finance & Investor Relations
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy
Mr. Patrick Helfrich	Vice President of Marketing & Commercial Strategy
Mr. Mike Gilligan	Senior Vice President of Sales

Important FAQs about investing in VCEL Stock from India :

What is Vericel share price today?

Vericel share price today stands at $52.00, Open: $54.91 ; Previous Close: $54.31 ; High: $54.90 ; Low: $51.99 ; 52 Week High: $63.00 ; 52 Week Low: $39.12.

The stock opens at $54.91, after a previous close of $54.31. The stock reached a daily high of $54.90 and a low of $51.99, with a 52-week high of $63.00 and a 52-week low of $39.12.

Can Indians buy Vericel shares?

Yes, Indians can invest in the Vericel (VCEL) from India.

With INDmoney, you can buy Vericel at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vericel at zero transaction cost.

How can I buy Vericel shares from India?

It is very easy to buy Vericel from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vericel (VCEL) be purchased?

Yes, you can buy fractional shares of Vericel with INDmoney app.

What are the documents required to start investing in Vericel stocks?

To start investing in Vericel, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.